Patent Grant
11304795
The present invention relates to devices, methods and systems for implanting stents. More particularly, the present invention relates to implantable stents having atraumatic spacer members.
An intraluminal prosthesis is a medical device used in the treatment of bodily lumens. One type of intraluminal prosthesis used in the repair and/or treatment of diseases in various body vessels is a stent. A stent is a generally longitudinal tubular device formed of biocompatible material which is useful to open and support various lumens in the body. For example, stents may be used in the vascular system, urogenital tract, gastrointestinal tract, esophageal tract, tracheal/bronchial tubes and bile duct, as well as in a variety of other applications in the body.
Lumen apposing metal stents are also used to drain pancreatic fluid collections and to provide direct biliary and gallbladder drainage. The positioning of the metal stent adjacent a cyst wall may result in post acute bleeding as the distal surface of the stent and the cyst wall come in contact as the cyst volume reduces due to drainage. Repetitive interaction between the end of the stent, such as a multi-terminal pointed stent end, with the cyst wall may be involved. Accordingly, there is an ongoing need to mitigate or remove this tissue interaction and negate the bleeding when an intraluminal prosthesis, such as a stent, is used for drainage.
The present disclosure is directed to various embodiments of a stent, for example a braided stent, having an integral spacer mechanism.
A first example stent includes a tubular body formed of one or more interwoven wires, the tubular body having first and second opposing open ends and a lumen extending therebetween, the tubular body defining a longitudinal axis extending between the first and second open ends, a first anchor member disposed adjacent the first open end and a second anchor member disposed adjacent the second open end, the first and second anchor members each extending radially outward from the tubular body, the first and second anchor members each having an outer diameter larger than an outer diameter of the tubular body disposed between the first and second anchor members, and a plurality of spacer members disposed around the first open end and extending longitudinally beyond the first open end, wherein when a pulling force is applied to the spacer members, the outer diameter of the tubular body is not reduced.
Alternatively or additionally to any of the above examples, each spacer member has first and second legs extending along a portion of the tubular body toward the second open end.
Alternatively or additionally to any of the above examples, the spacer members extend radially outward beyond the outer diameter of the tubular body.
Alternatively or additionally to any of the above examples, each spacer member is formed from a single wire loop.
Alternatively or additionally to any of the above examples, the spacer members are formed separately from the tubular body and attached to an inner wall of the tubular body.
Alternatively or additionally to any of the above examples, the spacer members are interwoven with the tubular body.
Alternatively or additionally to any of the above examples, the spacer members are less flexible than the tubular body.
Alternatively or additionally to any of the above examples, the plurality of spacer members includes a first group of spacer members with a first length and a second group of spacer members having a second length shorter than the first length.
Alternatively or additionally to any of the above examples, the first group of spacer members are more flexible than the second group of spacer members.
Alternatively or additionally to any of the above examples, the stent may further include a covering extending over an entirety of the tubular body, first and second anchor members, and the plurality of spacer members.
Alternatively or additionally to any of the above examples, at least one spacer member has a variable flexibility along its length.
Alternatively or additionally to any of the above examples, the at least one spacer member is formed from a tapered wire having a first thickness in a first region adjacent the tubular body, and a second thickness in a second region disposed furthest away from the tubular body.
Alternatively or additionally to any of the above examples, the second thickness is smaller than the first thickness, resulting in a greater flexibility in the second region.
Alternatively or additionally to any of the above examples, the first and second anchor members extend perpendicular to the longitudinal axis.
Alternatively or additionally to any of the above examples, the stent may further include a retrieval element disposed at the second open end.
Another example stent includes a tubular body formed of one or more interwoven wires, the tubular body having first and second opposing open ends and a lumen extending therebetween, the tubular body defining a longitudinal axis extending between the first and second open ends, a first group of spacer members disposed around the first open end and extending longitudinally beyond the first open end and extending radially outward beyond an outer diameter of the tubular body, the first group of spacer members having a first length, a second group of spacer members disposed around the first open end and extending longitudinally beyond the first open end and extending radially outward beyond an outer diameter of the tubular body, the second group of spacer members having a second length shorter than the first length, and wherein when a pulling force is applied to the first and/or second group of spacer members, the outer diameter of the tubular body is not reduced.
Alternatively or additionally to any of the above examples, a first anchor member disposed adjacent the first open end and a second anchor member disposed adjacent the second open end, the first and second anchor members each extending radially outward from the tubular body, the first and second anchor members each having an outer diameter larger than the outer diameter of the tubular body disposed between the first and second anchor members.
Alternatively or additionally to any of the above examples, the first group of spacer members are more flexible than the second group of spacer members.
Alternatively or additionally to any of the above examples, at least one spacer member in the first or second group of spacer members is formed from a tapered wire having a first thickness in a first region adjacent the tubular body, and a second thickness in a second region disposed furthest away from the tubular body, wherein the second thickness is smaller than the first thickness, resulting in a greater flexibility in the second region.
Another example is a method of draining a cyst comprising implanting a stent through a tissue wall with a first open end of the stent disposed within the cyst and a second open end of the stent disposed outside the cyst, the stent including a tubular body formed of one or more interwoven wires, the tubular body defining a lumen extending between the first and second open ends, the stent including a plurality of spacer members disposed around the first open end and extending longitudinally beyond the first open end, and draining fluid from the cyst through the lumen of the stent, wherein as the cyst drains, a wall of the cyst comes into contact with one or more of the plurality of spacer members, wherein the plurality of spacer members prevents the wall of the cyst from contacting the first open end of the stent.
The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present disclosure. The Figures, and Detailed Description, which follow, more particularly exemplify some of these embodiments.
In the drawings, which are not necessarily drawn to scale, like numerals may describe similar components in different views. The drawings illustrate generally, by way of example, but not by way of limitation, various embodiments discussed in the present document.
While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment described may include one or more particular features, structures, and/or characteristics. However, such recitations do not necessarily mean that all embodiments include the particular features, structures, and/or characteristics. Additionally, when particular features, structures, and/or characteristics are described in connection with one embodiment, it should be understood that such features, structures, and/or characteristics may also be used connection with other embodiments whether or not explicitly described unless clearly stated to the contrary.
The following detailed description should be read with reference to the drawings in which similar structures in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the disclosure.
The stent 10 may include multiple wires 15 of a metal material, such as nitinol or nitinol-containing material, or other nickel-titanium alloy, for example. In some instances, the wires 15 may have a diameter of about 0.011 inches, for example. The number of wires 15 and the diameters of the wires 15, which may be the same or different, depicted in
Desirably, the wires 15 are made from any suitable implantable material, including without limitation nitinol, stainless steel, cobalt-based alloy such as Elgiloy®, platinum, gold, titanium, tantalum, niobium, polymeric materials and combinations thereof. Useful and nonlimiting examples of polymeric stent materials include poly(L-lactide) (PLLA), poly(D,L-lactide) (PLA), poly(glycolide) (PGA), poly(L-lactide-co-D,L-lactide) (PLLA/PLA), poly(L-lactide-co-glycolide) (PLLA/PGA), poly(D,L-lactide-co-glycolide) (PLA/PGA), poly(glycolide-co-trimethylene carbonate) (PGA/PTMC), polydioxanone (PDS), Polycaprolactone (PCL), polyhydroxybutyrate (PHBT), poly(phosphazene) poly(D,L-lactide-co-caprolactone) PLA/PCL), poly(glycolide-co-caprolactone) (PGA/PCL), poly(phosphate ester) and the like. Wires made from polymeric materials may also include radiopaque materials, such as metallic-based powders, particulates or pastes which may be incorporated into the polymeric material. For example the radiopaque material may be blended with the polymer composition from which the polymeric wire is formed, and subsequently fashioned into the stent 10 as described herein. Alternatively, the radiopaque material may be applied to the surface of the metal or polymer wire 15 of the stent 10. In either embodiment, various radiopaque materials and their salts and derivatives may be used including, without limitation, bismuth, barium and its salts such as barium sulphate, tantalum, tungsten, gold, platinum and titanium, to name a few. Additional useful radiopaque materials may be found in U.S. Pat. No. 6,626,936, the contents of which are incorporated herein by reference. Metallic complexes useful as radiopaque materials are also contemplated. The stent may be selectively made radiopaque at desired areas along the wire or may be fully radiopaque.
In some instances, the wires 15 may have a composite construction having an inner core of tantalum, gold, platinum, tungsten, iridium or combination thereof and an outer member or layer of nitinol to provide a composite wire for improved radiopacity or visibility. In one example, the inner core may be platinum and the outer layer may be nitinol. The inner core of platinum may represent about at least 10% of the wire 15 based on the overall cross-sectional percentage. Moreover, nitinol that has not been treated for shape memory such as by heating, shaping and cooling the nitinol at its martensitic and austenitic phases, is also useful as the outer layer. Further details of such composite wires may be found in U.S. Pat. No. 7,101,392, the contents of which is incorporated herein by reference. The wires 15 may be made from nitinol, or a composite wire having a central core of platinum and an outer layer of nitinol. Further, the filling weld material, if required by welding processes such as MIG, may also be made from nitinol, stainless steel, cobalt-based alloy such as Elgiloy, platinum, gold, titanium, tantalum, niobium, and combinations thereof.
The tubular body 20 may have one or more anchor members 26, 28 adjacent the first and second ends, respectively. The anchor members 26, 28 may be regions that extend radially outward from the tubular body 20, forming flanges. In the example shown in
The stent 10 may include a plurality of atraumatic spacer members 30 disposed around the first end 22 of the tubular body, as shown in
In the example shown in
The legs 32, 34 from one spacer member 30 may overlap the legs 32, 34 of another spacer member 30 in some instances. For example, in some embodiments, the legs 32, 34 of a first spacer member 30 may extend in a first helical direction along the inner surface of the tubular body 20 while the legs 32, 34 of a second spacer member 30 may extend in an opposite second helical direction along the inner surface of the tubular body 20 and intersect the legs 32, 34 of the first spacer member 30. In other examples, all of the legs 32, 34 of all spacer members 30 extend along the interior of the tubular body 20 without contacting legs 32, 34 of another spacer member 30. For example, the legs 32, 34 of each spacer member 30 may extend in the same helical direction along the interior of the tubular body 20.
The spacer members 30 may be arranged uniformly around the circumference of the first end 22 and radiate outward in a radial direction. The spacer members 30 may be spaced apart, as shown in
The wire 35 forming the spacer members 30 may have the same or different properties than the wires 15 which form the tubular body 20. For example, the wires 35 may be of the same or different stiffness or flexibility, all of which may be tailored for a particular application. In some embodiments, the wire 35 forming spacer members 30 may be stiffer than the stent wires 15 forming the tubular body 20 of the stent 10. In some instances, the wire 35 forming the spacer members 30 may be formed of a different material and/or may have a different diameter than the stent wires 15. In some instances, the wire 35 forming the spacer members 30 may be stainless steel while the stent wires 15 may be formed of a nickel-titanium alloy, such as nitinol. The material forming the spacer member wires 35 may have a stiffness greater than, equal to, or less than the material forming the wires 15 of the tubular body 20 and/or the material forming the spacer member wires 35 may have a modulus of elasticity (Young's modulus) greater than, equal to, or less than the material forming the wires 15 of the tubular body 20. The choice of material, wire diameter and pre-treatment of the wires 35, 15 and stent configuration are some of the factors which may be varied to achieve particular stent properties. Additionally, at least one of the spacer members 30 may also be made radiopaque by various methods, for example with a coating or finish, with a band or as part of the stent material. Color or different finishes may also be added to the spacer members 30 to visually differentiate them from the rest of the stent wires 15.
The spacer members 30 are configured such that applying a pulling or squeezing force on the spacer members 30 does not reduce the outer diameter of the tubular body 20. In examples in which spacer members 30 are formed from additional wires attached to the previously formed tubular body 20, the attachment is such that pulling on the spacer members 30 does not reduce the outer diameter of the tubular body 20. For example, welding the spacer members 30 or using adhesive to attach the spacer members 30 to one or more wire cross-over points on the inner surface of the tubular body 20 may prevent the spacer members 30 from interacting with the weave or braided structure of the tubular body 20 to reduce its diameter when the spacer members 30 are pulled or squeezed. In examples where the spacer members 30 are formed from one or more wires used in forming the tubular body 20, the portion of the wire(s) forming the spacer members 30 may be stabilized relative to the tubular body 20 such that pulling on the spacer members 30 does not reduce the outer diameter of the tubular body 20. In one example, stabilizing may include welding one or more of the last wire cross-over points at the first end 22 of the tubular body where the wire forming the spacer member 30 exits the tubular body 20. In other examples, adhesive or additional wire wrapping may be used to stabilize the spacer members 30 relative to the tubular body 20. The spacer members 30 thus do not function as retrieval elements to reduce the diameter of the stent 10 for removal. In some examples, a separate retrieval element 80 may be disposed on the second end 24 and/or the first end 22 of the tubular body 20. In the example shown in
The spacer members 30 extend longitudinally beyond the first end 22 of the tubular body 20. The spacer members 30 may extend beyond the first end 22 of the tubular body 20 for a distance D. In some instances, distance D may be 5% to 50%, 10% to 50%, 10% to 30%, or 5% to 30% of the total length of the tubular body 20, for example. In some examples, the spacer members 30 may extend 8 mm to 15 mm beyond the first end 22. The spacer members 30 may also extend radially away from the tubular body 20, beyond the outer diameter of the tubular body 20 as measured at the first end 22. In the example shown in
The spacer members 30 may provide a structure which has the required stiffness to maintain the stent 10 in a spaced orientation away from the cyst wall 40, thus preventing damage to the tissue wall from contact with the first end 22 of the tubular body 20. In some examples, the flexibility of the spacer members 30 varies along their length. The spacer members 30 may be formed from a wire having a variable thickness along its length. In one example, as shown in
In some embodiments the stent 10, 100 may include a covering 70, 170 disposed over at least a portion of the tubular body 20, 120 of the stent 10, 100. For example, the covering 70, 170 may fully cover the entire length of the tubular body 20, 120 of the stent 10, 100, forming a fully covered stent in which all of the interstices defined in the braided or woven pattern are covered with the covering 70, 170 to prevent tissue in-growth and fluid leakage into the lumen of the tubular body 20, 120. In other examples, the covering 70, 170 may cover only a portion of the length of the tubular body 20, 120 of the stent 10, 100, forming a partially covered stent in which a portion of the interstices defined in the braided or woven pattern remain uncovered, allowing tissue in-growth. In some instances, the spacer members 30, 130 may be covered by the covering 70, 170, thus the entire stent 10, 100, including both the entire tubular body 20, 120 and the spacer members 30, 130 may be covered by the covering 70, 170. For instance, the covering 70, 170 may extend across and fill the space between adjacent sides of the loop formed by the wire(s) forming the spacer members 30, 130 while the gap between adjacent spacer members 30, 130 may be devoid of any covering material, permitting fluid to flow between the spacer members 30, 130 around the end of the stent 10, 100 and into the lumen of the stent 10, 100. In some instances, the stent 10, 100 may be dipped into a solution of silicone or other polymer to form the covering 70, 170. In other instances, a polymer sheet or tube may be placed around the tubular body 20, 120 and/or within the tubular body 20, 120 to form the covering 70, 170. The covering 70, 170 may be disposed on external or internal surfaces of the tubular body 20, 120, or on both the internal and external surfaces of the tubular body 20, 120, thereby embedding the stent 10, 100 in the polymeric material. The coating or covering may be a polymer covering, such as a polytetrafluoroethylene (PTFE) or silicone covering, however other coverings, particularly elastomeric polymers, may be used. Non-limiting examples of useful polymeric materials include polyesters, polypropylenes, polyethylenes, polyurethanes, polynaphthalenes, polytetrafluoroethylenes, expanded polytetrafluoroethylene, silicone, and combinations and copolymers thereof.
The first group of spacer members 230 may be more flexible than the second group of spacer members 231, allowing the first group of spacer members 230 to flex, bend or partially collapse as the cyst wall 40 advances towards the first end 222 of the tubular body 220. As with the spacer members 30 described above, the first and second groups of spacer members 230, 231 may have a variable flexibility along their length. In particular, one or both of the first and second groups of spacer members 230, 231 may have terminal ends 238 that are more flexible than first regions 236 adjacent the tubular body 320. As with the stent 10 described above, when the first and second groups of spacer members 230, 231 engage a lumen wall, the spacer members 230, 231 provide insufficient radial resistance to anchor the stent 200. Similar to the spacer members 30 discussed above, the spacer members 230, 231 are configured such that applying a pulling or squeezing force on the spacer members 230, 231 does not reduce the outer diameter of the tubular body 220.
A further example of a stent 300 with a tubular body 320 and a plurality of spacer members 330 is shown in
The wires 335 may be tapered to provide a variable flexibility along the spacer member 330. For example, the wires 335 may have a first thickness in the first region 336 adjacent the tubular body 320 and taper down to a second, smaller thickness in the region of the terminal end 338 of the spacer member 330, resulting in the terminal end 338 being more flexible than the first region 336. This allows the terminal end 338 of the spacer members 330 to flex or bend back toward the opposite end of the tubular body 320 upon contact with a tissue wall. The stiffer first region 336 holds the end of the tubular body 320 away from the tissue wall allowing fluid drainage around the first end 322 of the tubular body 320 into the lumen of the stent 300. The flexibility of the terminal end 338 of the spacer members 330 allows the spacer members 330 to gently engage the tissue wall below the stent 300, but the spacer members 330 provide insufficient radial resistance to anchor the stent 300 against lumen walls extending substantially parallel to the longitudinal axis. The stiffer first region 336 may provide sufficient resistance in a longitudinal direction to anchor the stent 300 disposed perpendicular to a tissue wall.
As with the stent 10, stents 100, 200, 300 and 400 may include a covering, similar to covering 70, 170 described above, disposed over at least a portion of the tubular body of the stent 100, 200, 300, 400. For example, the covering may fully cover the entire length of the tubular body of the stent 100, 200, 300, 400, forming a fully covered stent in which all of the interstices defined in the braided or woven pattern are covered with the covering to prevent tissue in-growth and fluid leakage into the lumen of the tubular body. In other examples, the covering may cover only a portion of the length of the tubular body of the stent 100, 200, 300, 400, forming a partially covered stent in which a portion of the interstices defined in the braided or woven pattern remain uncovered, allowing tissue in-growth. In some instances, the spacer members 130, 230, 330, 430 may be covered by the covering, thus the entire stent 100, 200, 300, 400, including both the entire tubular body and the spacer members 130, 230, 330, 430 may be covered by the covering. For instance, the covering may extend across and fill the space between adjacent sides of the loop formed by the wire(s) forming the spacer members 130, 230, 330, 430, while the gap between adjacent spacer members 130, 230, 330, 430 may be devoid of any covering material, permitting fluid to flow between the spacer members 130, 230, 330, 430 around the end of the stent 100, 200, 300, 400 and into the lumen of the stent 100, 200, 300, 400.
Various stent types and stent constructions may be employed for the stent 10, 100, 200, 300, 400. For example, the stent 10, 100, 200, 300, 400 may be a self-expanding stent or a balloon expandable stent. The stent 10, 100, 200, 300, 400 may be capable of radially contracting to a compressed or collapsed configuration for delivery, and then expandable to an expanded configuration during deployment in the body lumen. Thus, the stent 10, 100, 200, 300, 400 may be described as radially distensible or deformable. Self-expanding stents include those that have a spring-like action which causes the stent to radially expand, or stents which expand due to the memory properties of the stent material for a particular configuration at a certain temperature. The configuration of the stent may also be chosen from a host of geometries. For example, wire stents can be fastened into a continuous helical pattern, with or without a wave-like or zig-zag in the wire, to form a radially deformable stent. Individual rings or circular members can be linked together such as by struts, sutures, welding or interlacing or locking of the rings to form a tubular stent. In other embodiments, the stent 10, 100, 200, 300, 400 may be formed as a monolithic tubular member by etching or cutting a pattern of interconnected struts from a tube.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
This application claims priority under 35 U.S.C. § 119 to U.S. Provisional Application Ser. No. 62/576,890, filed Oct. 25, 2017, the entirety of which is incorporated herein by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 5064435 | Porter | Nov 1991 | A |
| 5474563 | Myler et al. | Dec 1995 | A |
| 5741333 | Frid | Apr 1998 | A |
| 5849037 | Frid | Dec 1998 | A |
| 5888201 | Stinson et al. | Mar 1999 | A |
| 5941895 | Myler et al. | Aug 1999 | A |
| 5980533 | Holman | Nov 1999 | A |
| 6120522 | Vrba et al. | Sep 2000 | A |
| 6240978 | Gianotti | Jun 2001 | B1 |
| 6241757 | An et al. | Jun 2001 | B1 |
| 6264689 | Colgan et al. | Jul 2001 | B1 |
| 6290721 | Heath | Sep 2001 | B1 |
| 6295714 | Roychowdhury et al. | Oct 2001 | B1 |
| 6302917 | Dua et al. | Oct 2001 | B1 |
| 6423084 | St. Germain | Jul 2002 | B1 |
| 6468303 | Amplatz et al. | Oct 2002 | B1 |
| 6558429 | Taylor | May 2003 | B2 |
| 6569181 | Burns | May 2003 | B1 |
| 6585758 | Chouinard et al. | Jul 2003 | B1 |
| 6620122 | Stinson et al. | Sep 2003 | B2 |
| 6626936 | Stinson | Sep 2003 | B2 |
| 6626939 | Burnside et al. | Sep 2003 | B1 |
| 6652577 | Gianotti | Nov 2003 | B2 |
| 6663663 | Kim et al. | Dec 2003 | B2 |
| 6792979 | Konya et al. | Sep 2004 | B2 |
| 6821291 | Bolea et al. | Nov 2004 | B2 |
| 6997945 | St. Germain | Feb 2006 | B2 |
| 7001423 | Euteneuer et al. | Feb 2006 | B2 |
| 7001425 | McCullagh et al. | Feb 2006 | B2 |
| 7018401 | Hyodoh et al. | Mar 2006 | B1 |
| 7048014 | Hyodoh et al. | May 2006 | B2 |
| 7101392 | Heath | Sep 2006 | B2 |
| 7160323 | Pulnev et al. | Jan 2007 | B2 |
| 7172617 | Colgan et al. | Feb 2007 | B2 |
| 7175655 | Molaei | Feb 2007 | B1 |
| 7311031 | McCullagh et al. | Dec 2007 | B2 |
| 7331990 | Gianotti | Feb 2008 | B2 |
| 7419502 | Pulnev et al. | Sep 2008 | B2 |
| 7419503 | Pulnev et al. | Sep 2008 | B2 |
| 7462192 | Norton et al. | Dec 2008 | B2 |
| 7476256 | Meade et al. | Jan 2009 | B2 |
| 7637938 | Brown et al. | Dec 2009 | B2 |
| 7655039 | Leanna et al. | Feb 2010 | B2 |
| 7670367 | Chouinard et al. | Mar 2010 | B1 |
| 7670369 | Schaeffer | Mar 2010 | B2 |
| 7736386 | Pulnev et al. | Jun 2010 | B2 |
| 7763011 | Ortiz et al. | Jul 2010 | B2 |
| 7763068 | Pulnev et al. | Jul 2010 | B2 |
| 7815591 | Levine et al. | Oct 2010 | B2 |
| 7857844 | Norton et al. | Dec 2010 | B2 |
| 7927366 | Pulnev et al. | Apr 2011 | B2 |
| 8092512 | Rudnick et al. | Jan 2012 | B2 |
| 8105392 | Durgin | Jan 2012 | B2 |
| 8109992 | Pulnev et al. | Feb 2012 | B2 |
| 8114147 | Wood et al. | Feb 2012 | B2 |
| 8151682 | Lilburn et al. | Apr 2012 | B2 |
| 8197528 | Colgan et al. | Jun 2012 | B2 |
| 8197529 | Cully et al. | Jun 2012 | B2 |
| 8211186 | Belhe et al. | Jul 2012 | B2 |
| 8262719 | Erickson et al. | Sep 2012 | B2 |
| 8357193 | Phan et al. | Jan 2013 | B2 |
| 8414635 | Hyodoh et al. | Apr 2013 | B2 |
| 8425539 | Binmoeller et al. | Apr 2013 | B2 |
| 8454632 | Binmoeller et al. | Jun 2013 | B2 |
| 8459164 | Lilburn et al. | Jun 2013 | B2 |
| 8491647 | Colgan et al. | Jul 2013 | B2 |
| 8623071 | Lundkvist et al. | Jan 2014 | B2 |
| 8647381 | Essinger et al. | Feb 2014 | B2 |
| 8677874 | Lilburn et al. | Mar 2014 | B2 |
| 8784473 | Tupil et al. | Jul 2014 | B2 |
| 8926686 | King | Jan 2015 | B2 |
| 9044300 | Belhe et al. | Jun 2015 | B2 |
| 9265634 | Brady et al. | Feb 2016 | B2 |
| 9439791 | Vong et al. | Sep 2016 | B2 |
| 9526648 | Sharma | Dec 2016 | B2 |
| 9566182 | Durgin | Feb 2017 | B2 |
| 10076330 | Sander et al. | Sep 2018 | B2 |
| 20030032967 | Park et al. | Feb 2003 | A1 |
| 20030083734 | Friedrich et al. | May 2003 | A1 |
| 20040093058 | Cottone et al. | May 2004 | A1 |
| 20050049682 | Leanna | Mar 2005 | A1 |
| 20060190075 | Jordan | Aug 2006 | A1 |
| 20060276887 | Brady et al. | Dec 2006 | A1 |
| 20070112415 | Bartlett | May 2007 | A1 |
| 20070112437 | Shank | May 2007 | A1 |
| 20070179590 | Lu et al. | Aug 2007 | A1 |
| 20080243151 | Binmoeller et al. | Oct 2008 | A1 |
| 20090177268 | Lundkvist et al. | Jul 2009 | A1 |
| 20090248171 | Levine et al. | Oct 2009 | A1 |
| 20090281379 | Binmoeller et al. | Nov 2009 | A1 |
| 20100305590 | Holmes et al. | Dec 2010 | A1 |
| 20110060398 | Tupil et al. | Mar 2011 | A1 |
| 20110071613 | Wood et al. | Mar 2011 | A1 |
| 20110190662 | McWeeney | Aug 2011 | A1 |
| 20110190905 | Behan | Aug 2011 | A1 |
| 20120095543 | Pal | Apr 2012 | A1 |
| 20130030351 | Belhe et al. | Jan 2013 | A1 |
| 20130053950 | Rowe et al. | Feb 2013 | A1 |
| 20130144372 | Wood et al. | Jun 2013 | A1 |
| 20130197623 | McHugo | Aug 2013 | A1 |
| 20130245745 | Vong et al. | Sep 2013 | A1 |
| 20130253546 | Sander | Sep 2013 | A1 |
| 20140074219 | Hingston et al. | Mar 2014 | A1 |
| 20140074220 | Clerc et al. | Mar 2014 | A1 |
| 20140081382 | Leanna et al. | Mar 2014 | A1 |
| 20140081416 | Clerc et al. | Mar 2014 | A1 |
| 20140156023 | Blackmon | Jun 2014 | A1 |
| 20140243992 | Walsh et al. | Aug 2014 | A1 |
| 20140350694 | Behan | Nov 2014 | A1 |
| 20140364959 | Attar et al. | Dec 2014 | A1 |
| 20150134074 | Walsh et al. | May 2015 | A1 |
| 20150282922 | Hingston et al. | Oct 2015 | A1 |
| 20150290005 | Wainwright et al. | Oct 2015 | A1 |
| 20150342770 | Howard | Dec 2015 | A1 |
| 20160081832 | Hingston et al. | Mar 2016 | A1 |
| 20160256257 | Rasmussen | Sep 2016 | A1 |
| 20170079812 | Lam et al. | Mar 2017 | A1 |
| 20180125633 | Fikfak | May 2018 | A1 |
| 20180263797 | Eller | Sep 2018 | A1 |
| 20180280166 | Walsh | Oct 2018 | A1 |
| 20200261205 | Folan | Aug 2020 | A1 |
| Number | Date | Country |
|---|---|---|
| 1065996 | Dec 2003 | EP |
| 1229864 | Apr 2005 | EP |
| 1001718 | Sep 2005 | EP |
| 975279 | Feb 2007 | EP |
| 1560544 | Jan 2008 | EP |
| 2194887 | Jun 2010 | EP |
| 2273942 | Jan 2011 | EP |
| 2276390 | Jan 2011 | EP |
| 1598032 | Mar 2011 | EP |
| 1755462 | Mar 2011 | EP |
| 2389877 | Nov 2011 | EP |
| 2391752 | Dec 2011 | EP |
| 1833417 | Feb 2012 | EP |
| 2407127 | Apr 2014 | EP |
| 2434961 | Jan 2015 | EP |
| 2011509124 | Mar 2011 | JP |
| 2013504375 | Feb 2013 | JP |
| 2008103572 | Aug 2008 | WO |
| 2012087301 | Jun 2012 | WO |
| 2016134148 | Aug 2016 | WO |
| WO-2016134148 | Aug 2016 | WO |
| Entry |
|---|
| International Search Report and Written Opinion dated Jan. 22, 2019 for International Application No. PCT/US2018/057308. |
| “Axios Stent and Electrocautery Enhanced Delivery System,” Boston Scientific, 4 pages, Dec. 2015. |
| Blackwell, What is the mean Lower Esophageal Sphincter Pressure in normal subjects?, Oleso Knowledge, 2 pages, May 1991. |
| Booth, “Vomiting Larry: a simulated vomiting system for assessing environmental contamination from projectile vomiting related to norovirus infection,” Journal of Infection Prevention, 15(5): 8 pages, Sep. 2014. |
| Bowen, “Phisiology of Vomiting,” VIVO Pathophysiology, 4 pages, accessed Aug. 11, 2017. |
| Cowgill et al., “Normal lower esophageal sphincter pressure and length does not impact outcome after laparoscopic Nissen fundoplication,” PubMed,11(6): 2 pages, Jun. 2007. |
| Dua et al., “Self-expanding metal esophageal stent with anti-reflux mechanism,” Gastrointestinal Endoscopy, 53(6): 2 pages, May 2001. |
| “Gastroesophageal Reflux Disease,” National Cancer Institute, 2 pages, accessed Aug. 11, 2017. |
| Hayden et al., “Fecal Incontinence: Etiology, Evaluation, and Treatment,” Clinics in Colon and Rectal Surgery, 24(1): 9 pages, Mar. 2011. |
| Mashimo et al., “Physiology of esophageal motility,” GI Motility online, 36 pages, May 16, 2006. |
| “Polyimide Tubing: Dispelling the Myths,” MicroLumen High Performance Medical Tubing, 8 pages, 2008. |
| Sajadi et al., “Artificial Urinary Sphincter Placement Treatment and Management,” Medscape, 1 page, May 16, 2016. |
| Mukai et al., “Interventional Endoscopy for the Treatment of Pancreatic Pseudocyst and Walled-Off Necrosis”, Journal of Hepato-Biliary-Pancreatic Sciences, 21: E75-E85, Oct. 21, 2014. |
| Siddiqui et al., “EUS-guided drainage of peripancreatic fluid collections and necrosis by using a novel lumen-apposing stent: a large retrospective, multicenter U.S. experience,” Gastrointestinal Endoscopy Journal, 83(4): 9 pages, Apr. 1, 2016. |
| Lang et al., “EUS-guided drainage of peripancreatic fluid collections with lumen-apposing metal stents and plastic double-pigtail stents: comparison of efficacy and adverse event rates,” Gastrointestinal Endoscopy Journal, 29 pages, Jul. 13, 2017. |
| Siddiqui et al., “Fully covered self-expanding metal stents versus lumen-apposing fully covered self-expanding metal stent versus plastic stents for endoscopic drainage of pancreatic walled-off necrosis: clinical outcomes and success,” Gastrointestinal Endoscopy Journal, 85(4): 8 pages, Apr. 2017 (Epub date of Aug. 24, 2016). |
| Number | Date | Country | |
|---|---|---|---|
| 20190117370 A1 | Apr 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62576890 | Oct 2017 | US |
